Literature DB >> 23690155

Incidence and risk factors for pulmonary embolism after primary musculoskeletal tumor surgery.

Koichi Ogura1, Hideo Yasunaga, Hiromasa Horiguchi, Kazuhiko Ohe, Hirotaka Kawano.   

Abstract

BACKGROUND: Limited information is available regarding the incidence, risk factors, and optimal prophylaxis in orthopaedic oncology patients, although malignancy and major orthopaedic surgery are associated with an increased pulmonary embolism (PE) risk. QUESTIONS/PURPOSES: We aimed to investigate the incidence of PE after musculoskeletal tumor surgery in Japanese patients and analyze the potential risk factors for PE.
METHODS: We retrospectively identified 3750 patients (1981 males, 1769 females) who underwent musculoskeletal tumor surgery during 2007 to 2010 using the Japanese Diagnostic Procedure Combination administrative database. Data collected included sex, age, primary diagnosis, type of surgery, duration of anesthesia, and comorbidities that may affect PE incidence. Univariate logistic regression analyses were performed to examine the relationship of each factor with PE occurrence.
RESULTS: We identified 10 patients with PE during the survey period. A primary malignant bone tumor was associated with a significantly higher risk of PE than a primary malignant soft tissue tumor (odds ratio [OR], 5.58; 95% CI, 1.39-22.42). Bone tumor resection (OR, 7.94; 95% CI, 1.77-35.59) and prosthetic reconstruction (OR, 9.15; 95% CI, 1.52-55.07) were associated with a significantly higher risk of PE than soft tissue tumor resection.
CONCLUSIONS: Malignant bone tumors and bone tumor resections have a higher risk of PE than malignant soft tissue neoplasms and soft tissue resections. Both populations might require PE prophylaxis as it is likely that the risk is greater than with other major orthopaedic surgery, but data accumulation should continue, and further investigation should be done to clarify details of the incidence, risk factors, and optimal prophylaxis for PE. LEVEL OF EVIDENCE: Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2013        PMID: 23690155      PMCID: PMC3773132          DOI: 10.1007/s11999-013-3073-9

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  27 in total

Review 1.  Prevention of venous thromboembolism.

Authors:  W H Geerts; J A Heit; G P Clagett; G F Pineo; C W Colwell; F A Anderson; H B Wheeler
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.

Authors:  J A Heit; M D Silverstein; D N Mohr; T M Petterson; W M O'Fallon; L J Melton
Journal:  Arch Intern Med       Date:  2000-03-27

3.  Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis.

Authors:  B A Hutten; M H Prins; M Gent; J Ginsberg; J G Tijssen; H R Büller
Journal:  J Clin Oncol       Date:  2000-09       Impact factor: 44.544

4.  Incidence and characteristics of pulmonary thromboembolism in Japan 2000.

Authors:  Osamu Kitamukai; Masahito Sakuma; Tohru Takahashi; Yutaka Kagaya; Jun Watanabe; Kunio Shirato
Journal:  Intern Med       Date:  2003-11       Impact factor: 1.271

5.  Anticoagulants, venous thromboembolism, and the cancer patient.

Authors:  F D Moore; R T Osteen; D D Karp; G Steele; R E Wilson
Journal:  Arch Surg       Date:  1981-04

6.  Factors affecting the occurrence of pulmonary embolism after spinal surgery: data from the national administrative database in Japan.

Authors:  Kazuhiro Masuda; Hirotaka Chikuda; Hideo Yasunaga; Nobuhiro Hara; Hiromasa Horiguchi; Shinya Matsuda; Katsushi Takeshita; Hiroshi Kawaguchi; Kozo Nakamura
Journal:  Spine J       Date:  2012-11-14       Impact factor: 4.166

7.  Inferior vena cava filters prevent pulmonary emboli in patients with metastatic pathologic fractures of the lower extremity.

Authors:  Joseph Benevenia; Christopher Bibbo; Dipak V Patel; Mark G Grossman; Philip F Bahramipour; Peter J Pappas
Journal:  Clin Orthop Relat Res       Date:  2004-09       Impact factor: 4.176

Review 8.  Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis.

Authors:  G P Clagett; J S Reisch
Journal:  Ann Surg       Date:  1988-08       Impact factor: 12.969

9.  Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

Authors:  Paolo Prandoni; Anthonie W A Lensing; Andrea Piccioli; Enrico Bernardi; Paolo Simioni; Bruno Girolami; Antonio Marchiori; Paola Sabbion; Martin H Prins; Franco Noventa; Antonio Girolami
Journal:  Blood       Date:  2002-07-12       Impact factor: 22.113

10.  Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta-analysis.

Authors:  P Mismetti; S Laporte; P Zufferey; M Epinat; H Decousus; M Cucherat
Journal:  J Thromb Haemost       Date:  2004-07       Impact factor: 5.824

View more
  3 in total

1.  What is the effect of advanced age and comorbidity on postoperative morbidity and mortality after musculoskeletal tumor surgery?

Authors:  Koichi Ogura; Hideo Yasunaga; Hiromasa Horiguchi; Kiyohide Fushimi; Hirotaka Kawano
Journal:  Clin Orthop Relat Res       Date:  2014-08-20       Impact factor: 4.176

2.  High Risk of Venous Thromboembolism After Surgery for Long Bone Metastases: A Retrospective Study of 682 Patients.

Authors:  Olivier Q Groot; Paul T Ogink; Stein J Janssen; Nuno Rui Paulino Pereira; Santiago Lozano-Calderon; Kevin Raskin; Francis Hornicek; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2018-10       Impact factor: 4.176

3.  Prevalence and risk factors of preoperative venous thromboembolism in patients with malignant musculoskeletal tumors: an analysis based on D-dimer screening and imaging.

Authors:  Kenta Hayashida; Yusuke Kawabata; Keiju Saito; Shintaro Fujita; Hyonmin Choe; Ikuma Kato; Masanobu Takeyama; Yutaka Inaba
Journal:  Thromb J       Date:  2022-04-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.